KlebSeq, a diagnostic tool for surveillance, detection, and monitoring of Klebsiella pneumoniae

Journal of Clinical Microbiology

Volumn 54, Issue 10, 2016, Pages 2582-2596

  Bowers, Jolene R ^a   Lemmer, Darrin ^a   Sahl, Jason W ^b   Pearson, Talima ^b   Driebe, Elizabeth M ^a   Wojack, Bette ^c   Saubolle, Michael A ^c   Engelthaler, David M ^a   Keim, Paul ^a,b  

^a TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^b Center for Microbial Genetics and Genomics   (United States)

^c BANNER HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPLICON; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENOME; BACTERIAL VIRULENCE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENE SEQUENCE; GENETIC PROCEDURES; HIGH THROUGHPUT SEQUENCING; KLEBSEQ; KLEBSIELLA PNEUMONIAE; MONITORING; NEXT GENERATION SEQUENCING; NONHUMAN; OPEN READING FRAME; PHYLOGENY; PLASMID; PRIORITY JOURNAL; PROCESS DESIGN; SENSITIVITY AND SPECIFICITY; SEQUENCE ALIGNMENT; SINGLE NUCLEOTIDE POLYMORPHISM; VALIDATION STUDY; WHOLE GENOME SEQUENCING; CROSS INFECTION; DNA SEQUENCE; EPIDEMIOLOGICAL MONITORING; GENETICS; GENOTYPING TECHNIQUE; HUMAN; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTIONS; MASS SCREENING; MOLECULAR DIAGNOSIS; PROCEDURES;

VIRULENCE FACTOR;

CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; EPIDEMIOLOGICAL MONITORING; GENOTYPING TECHNIQUES; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MASS SCREENING; MOLECULAR DIAGNOSTIC TECHNIQUES; SEQUENCE ANALYSIS, DNA; VIRULENCE FACTORS;

EID: 84991215163     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00927-16     Document Type: Article

References (85)

1. Montgomerie JZ. 1979. Epidemiology of Klebsiella and hospital-associated infections. Rev Infect Dis 1:736-753. http://dx.doi.org/10.1093/clinids/1.5.736.
2. Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, Lynfield R, Maloney M, McAllister-Hollod L, Nadle J, Ray SM, Thompson DL, Wilson LE, Fridkin SK, Emerging Infections Program Healthcare-Associated Infections, Antimicrobial Use Prevalence Survey Team. 2014. Multistate point-prevalence survey of health care-associated infections. N Engl J Med 370:1198-1208. http://dx.doi.org/10.1056/NEJMoa1306801.
3. Centers for Disease Control and Prevention. 2013. Antibiotic resistance threats in the United States, 2013. Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf.
4. Xu Y, Gu B, Huang M, Liu H, Xu T, Xia W, Wang T. 2015. Epidemiology of carbapenem resistant Enterobacteriaceae (CRE) during 2000-2012 in Asia. J Thorac Dis 7:376-385. http://dx.doi.org/10.3978/j.issn.2072-1439.2014.12.33.
5. World Health Organization. 2014. Antimicrobial resistance global report on surveillance. World Health Organization, Geneva, Switzerland. http://apps.who.int/iris/bitstream/10665/112642/1/9789241564748-eng.pdf.
6. Correa L, Martino MD, Siqueira I, Pasternak J, Gales AC, Silva CV, Camargo TZ, Scherer PF, Marra AR. 2013. A hospital-based matched case-control study to identify clinical outcome and risk factors associated with carbapenem-resistant Klebsiella pneumoniae infection. BMC Infect Dis 13:80. http://dx.doi.org/10.1186/1471-2334-13-80.
7. Kitchel B, Sundin DR, Patel JB. 2009. Regional dissemination of KPC-producing Klebsiella pneumoniae. Antimicrob Agents Chemother 53:4511-4513. http://dx.doi.org/10.1128/AAC.00784-09.
8. Frasson I, Lavezzo E, Franchin E, Toppo S, Barzon L, Cavallaro A, Richter SN, Palu G. 2012. Antimicrobial treatment and containment measures for an extremely drug-resistant Klebsiella pneumoniae ST101 isolate carrying pKPN101-IT, a novel fully sequenced bla(KPC-2) plasmid. J Clin Microbiol 50:3768-3772. http://dx.doi.org/10.1128/JCM.01892-12.
9. Lascols C, Peirano G, Hackel M, Laupland KB, Pitout JD. 2013. Surveillance and molecular epidemiology of Klebsiella pneumoniae isolates that produce carbapenemases: first report of OXA-48-like enzymes in North America. Antimicrob Agents Chemother 57:130-136. http://dx.doi.org/10.1128/AAC.01686-12.
10. Bialek-Davenet S, Criscuolo A, Ailloud F, Passet V, Jones L, Delannoy-Vieillard AS, Garin B, Le Hello S, Arlet G, Nicolas-Chanoine MH, Decre D, Brisse S. 2014. Genomic definition of hypervirulent and multidrug-resistant Klebsiella pneumoniae clonal groups. Emerg Infect Dis 20:1812-1820. http://dx.doi.org/10.3201/eid2011.140206.
11. Nagasaka Y, Kimura K, Yamada K, Wachino J, Jin W, Notake S, Yanagisawa H, Arakawa Y. 2015. Genetic profiles of fluoroquinolone-nonsusceptible Klebsiella pneumoniae among cephalosporin-resistant K. pneumoniae. Microb Drug Resist 21:224-233. http://dx.doi.org/10.1089/mdr.2014.0150.
12. Liu Y, Wan LG, Deng Q, Cao XW, Yu Y, Xu QF. 2015. First description of NDM-1-, KPC-2-, VIM-2- and IMP-4-producing Klebsiella pneumoniae strains in a single Chinese teaching hospital. Epidemiol Infect 143:376-384. http://dx.doi.org/10.1017/S0950268814000995.
13. Cubero M, Grau I, Tubau F, Pallares R, Dominguez MA, Linares J, Ardanuy C. 2016. Hypervirulent Klebsiella pneumoniae clones causing bacteraemia in adults in a teaching hospital in Barcelona, Spain (2007-2013). Clin Microbiol Infect 22:154-160. http://dx.doi.org/10.1016/j.cmi.2015.09.025.
14. Jacobson RK, Manesen MR, Moodley C, Smith M, Williams SG, Nicol MP, Bamford CM. 2015. Molecular characterisation and epidemiological investigation of an outbreak of blaOXA-181 carbapenemase-producing isolates of Klebsiella pneumoniae in South Africa. S Afr Med J 105:1030-1035. http://dx.doi.org/10.7196/SAMJ.2015.v105i12.9926.
15. Zhu J, Sun L, Ding B, Yang Y, Xu X, Liu W, Zhu D, Yang F, Zhang H, Hu F. 2016. Outbreak of NDM-1-producing Klebsiella pneumoniae ST76 and ST37 isolates in neonates. Eur J Clin Microbiol Infect Dis http://dx.doi.org/10.1007/s10096-016-2578-z.
16. Viau RA, Hujer AM, Marshall SH, Perez F, Hujer KM, Briceno DF, Dul M, Jacobs MR, Grossberg R, Toltzis P, Bonomo RA. 2012. "Silent" dissemination of Klebsiella pneumoniae isolates bearing K. pneumoniae carbapenemase in a long-term care facility for children and young adults in northeast Ohio. Clin Infect Dis 54:1314-1321. http://dx.doi.org/10.1093/cid/cis036.
17. Bowers JR, Kitchel B, Driebe EM, MacCannell DR, Roe C, Lemmer D, de Man T, Rasheed JK, Engelthaler DM, Keim P, Limbago BM. 2015. Genomic analysis of the emergence and rapid global dissemination of the clonal group 258 Klebsiella pneumoniae pandemic. PLoS One 10:e0133727. http://dx.doi.org/10.1371/journal.pone.0133727.
18. Zheng R, Zhang Q, Guo Y, Feng Y, Liu L, Zhang A, Zhao Y, Yang X, Xia X. 2016. Outbreak of plasmid-mediated NDM-1-producing Klebsiella pneumoniae ST105 among neonatal patients in Yunnan, China. Ann Clin Microbiol Antimicrob 15:10. http://dx.doi.org/10.1186/s12941-016-0124-6.
19. Pena I, Picazo JJ, Rodriguez-Avial C, Rodriguez-Avial I. 2014. Carbapenemase-producing Enterobacteriaceae in a tertiary hospital in Madrid, Spain: high percentage of colistin resistance among VIM-1-producing Klebsiella pneumoniae ST11 isolates. Int J Antimicrob Agents 43:460-464. http://dx.doi.org/10.1016/j.ijantimicag.2014.01.021.
20. Voulgari E, Gartzonika C, Vrioni G, Politi L, Priavali E, Levidiotou-Stefanou S, Tsakris A. 2014. The Balkan region: NDM-1-producing Klebsiella pneumoniae ST11 clonal strain causing outbreaks in Greece. J Antimicrob Chemother 69:2091-2097. http://dx.doi.org/10.1093/jac/dku105.
21. Woodford N, Turton JF, Livermore DM. 2011. Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol Rev 35:736-755. http://dx.doi.org/10.1111/j.1574-6976.2011.00268.x.
22. Swaminathan M, Sharma S, Poliansky Blash S, Patel G, Banach DB, Phillips M, LaBombardi V, Anderson KF, Kitchel B, Srinivasan A, Calfee DP. 2013. Prevalence and risk factors for acquisition of carbapenem-resistant Enterobacteriaceae in the setting of endemicity. Infect Control Hosp Epidemiol 34:809-817. http://dx.doi.org/10.1086/671270.
23. Pena C, Pujol M, Ardanuy C, Ricart A, Pallares R, Linares J, Ariza J, Gudiol F. 1998. Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum beta-lactamases. Antimicrob Agents Chemother 42:53-58.
24. Tischendorf J, de Avila RA, Safdar N. 2016. Risk of infection following colonization with carbapenem-resistant Enterobactericeae [sic]: a systematic review. Am J Infect Control 44:539-543. http://dx.doi.org/10.1016/j.ajic.2015.12.005.
25. Amit S, Mishali H, Kotlovsky T, Schwaber MJ, Carmeli Y. 2015. Bloodstream infections among carriers of carbapenem-resistant Klebsiella pneumoniae: etiology, incidence and predictors. Clin Microbiol Infect 21:30-34. http://dx.doi.org/10.1016/j.cmi.2014.08.001.
26. Thaden JT, Lewis SS, Hazen KC, Huslage K, Fowler VG, Jr, Moehring RW, Chen LF, Jones CD, Moore ZS, Sexton DJ, Anderson DJ. 2014. Rising rates of carbapenem-resistant enterobacteriaceae in community hospitals: a mixed-methods review of epidemiology and microbiology practices in a network of community hospitals in the southeastern United States. Infect Control Hosp Epidemiol 35:978-983. http://dx.doi.org/10.1086/677157.
27. Bassyouni RH, Gaber SN, Wegdan AA. 2015. Fecal carriage of extended-spectrum beta-lactamase- and AmpC-producing Escherichia coli among healthcare workers. J Infect Dev Ctries 9:304-308. http://dx.doi.org/10.3855/jidc.5633.
28. Papadimitriou-Olivgeris M, Marangos M, Fligou F, Christofidou M, Sklavou C, Vamvakopoulou S, Anastassiou ED, Filos KS. 2013. KPC-producing Klebsiella pneumoniae enteric colonization acquired during intensive care unit stay: the significance of risk factors for its development and its impact on mortality. Diagn Microbiol Infect Dis 77:169-173. http://dx.doi.org/10.1016/j.diagmicrobio.2013.06.007.
29. Monari C, Merlini L, Nardelli E, Cacioni M, Repetto A, Mencacci A, Vecchiarelli A. 2016. Carbapenem-resistant Klebsiella pneumoniae: results of a laboratory surveillance program in an Italian general hospital (August 2014-January 2015): surveillance of carbapenem-resistant Klebsiella pneumoniae. Adv Exp Med Biol 901:91-101. http://dx.doi.org/10.1007/5584-2015-5018.
30. Voor in 't Holt AF, Severin JA, Goessens WH, Te Witt R, Vos MC. 2015. Instant typing is essential to detect transmission of extended-spectrum beta-lactamase-producing Klebsiella species. PLoS One 10:e0136135. http://dx.doi.org/10.1371/journal.pone.0136135.
31. Viau R, Frank KM, Jacobs MR, Wilson B, Kaye K, Donskey CJ, Perez F, Endimiani A, Bonomo RA. 2016. Intestinal carriage of carbapenemase-producing organisms: current status of surveillance methods. Clin Microbiol Rev 29:1-27. http://dx.doi.org/10.1128/CMR.00108-14.
32. Lee BY, Bartsch SM, Wong KF, McKinnell JA, Slayton RB, Miller LG, Cao C, Kim DS, Kallen AJ, Jernigan JA, Huang SS. 2016. The potential trajectory of carbapenem-resistant Enterobacteriaceae, an emerging threat to health-care facilities, and the impact of the Centers for Disease Control and Prevention toolkit. Am J Epidemiol 183:471-479. http://dx.doi.org/10.1093/aje/kwv299.
33. Parker VA, Logan CK, Currie B. 2014. Carbapenem-resistant Enterobacteriaceae (CRE) control and prevention toolkit. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/professionals/quality-patient-safety/patient-safety-resources/resources/cretoolkit/index.html.
34. Lucet JC, Decre D, Fichelle A, Joly-Guillou ML, Pernet M, Deblangy C, Kosmann MJ, Regnier B. 1999. Control of a prolonged outbreak of extended-spectrum beta-lactamase-producing Enterobacteriaceae in a university hospital. Clin Infect Dis 29:1411-1418. http://dx.doi.org/10.1086/313511.
35. Schwaber MJ, Carmeli Y. 2014. An ongoing national intervention to contain the spread of carbapenem-resistant enterobacteriaceae. Clin Infect Dis 58:697-703. http://dx.doi.org/10.1093/cid/cit795.
36. Hayden MK, Lin MY, Lolans K, Weiner S, Blom D, Moore NM, Fogg L, Henry D, Lyles R, Thurlow C, Sikka M, Hines D, Weinstein RA, Centers for Disease Control and Prevention Epicenters Program. 2015. Prevention of colonization and infection by Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae in long-term acute-care hospitals. Clin Infect Dis 60:1153-1161. http://dx.doi.org/10.1093/cid/ciu1173.
37. Epson EE, Pisney LM, Wendt JM, MacCannell DR, Janelle SJ, Kitchel B, Rasheed JK, Limbago BM, Gould CV, Kallen AJ, Barron MA, Bamberg WM. 2014. Carbapenem-resistant Klebsiella pneumoniae producing New Delhi metallo-beta-lactamase at an acute care hospital, Colorado, 2012. Infect Control Hosp Epidemiol 35:390-397. http://dx.doi.org/10.1086/675607.
38. Pisney LM, Barron MA, Kassner E, Havens D, Madinger NE. 2014. Carbapenem-resistant Enterobacteriaceae rectal screening during an outbreak of New Delhi metallo-beta-lactamase-producing Klebsiella pneumoniae at an acute care hospital. Infect Control Hosp Epidemiol 35:434-436. http://dx.doi.org/10.1086/675597.
39. Dhar S, Martin ET, Lephart PR, McRoberts JP, Chopra T, Burger TT, Tal-Jasper R, Hayakawa K, Ofer-Friedman H, Lazarovitch T, Zaidenstein R, Perez F, Bonomo RA, Kaye KS, Marchaim D. 2016. Risk factors and outcomes for carbapenem-resistant Klebsiella pneumoniae isolation, stratified by its multilocus sequence typing: ST258 versus non-ST258. Open Forum Infect Dis 3:ofv213. http://dx.doi.org/10.1093/ofid/ofv213.
40. Wendt JM, Kaul D, Limbago BM, Ramesh M, Cohle S, Denison AM, Driebe EM, Rasheed JK, Zaki SR, Blau DM, Paddock CD, McDougal LK, Engelthaler DM, Keim PS, Roe CC, Akselrod H, Kuehnert MJ, Basavaraju SV. 2014. Transmission of methicillin-resistant Staphylococcus aureus infection through solid organ transplantation: confirmation via whole genome sequencing. Am J Transplant 14:2633-2639. http://dx.doi.org/10.1111/ajt.12898.
41. Snitkin ES, Zelazny AM, Thomas PJ, Stock F, NISC Comparative Sequencing Program Group, Henderson DK, Palmore TN, Segre JA. 2012. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med 4:148ra116. http://dx.doi.org/10.1126/scitranslmed.3004129.
42. Iqbal S, Quigley EM. 2016. Progress in our understanding of the gut microbiome: implications for the clinician. Curr Gastroenterol Rep 18:49. http://dx.doi.org/10.1007/s11894-016-0524-y.
43. Cope EK, Lynch SV. 2015. Novel microbiome-based therapeutics for chronic rhinosinusitis. Curr Allergy Asthma Rep 15:504. http://dx.doi.org/10.1007/s11882-014-0504-y.
44. Millares L, Perez-Brocal V, Ferrari R, Gallego M, Pomares X, Garcia-Nunez M, Monton C, Capilla S, Monso E, Moya A. 2015. Functional metagenomics of the bronchial microbiome in COPD. PLoS One 10:e0144448. http://dx.doi.org/10.1371/journal.pone.0144448.
45. Colman RE, Anderson J, Lehmkuhl E, Lemmer D, Heaton H, Georghiou SB, Wiggins K, Crudu V, Cohen T, Rodwell TC, Engelthaler DM. 2016. Rapid drug susceptibility testing of drug resistant Mycobacterium tuberculosis directly from clinical samples by use of amplicon sequencing: a proof-of-concept study. J Clin Microbiol 54:2058-2067. http://dx.doi.org/10.1128/JCM.00535-16.
46. Laine S. 2013. FDA allows marketing of four "next generation" gene sequencing devices. U.S. Food and Drug Administration, Silver Spring, MD. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm375742.htm. Accessed 31 July 2016.
47. Gilbert JA, Meyer F, Jansson J, Gordon J, Pace N, Tiedje J, Ley R, Fierer N, Field D, Kyrpides N, Glockner FO, Klenk HP, Wommack KE, Glass E, Docherty K, Gallery R, Stevens R, Knight R. 2010. The Earth Microbiome Project: meeting report of the "1 EMP Meeting on Sample Selection and Acquisition" at Argonne National Laboratory October 6 2010. Stand Genomic Sci 3:249-253. http://dx.doi.org/10.4056/aigs.1443528.
48. Sahl JW, Lemmer D, Travis J, Schupp J, Gillece J, Aziz M, Driebe E, Drees K, Hicks N, Williamson C, Hepp C, Smith D, Roe C, Engelthaler D, Wagner D, Keim P. 2016. The northern Arizona SNP pipeline (NASP): accurate, flexible, and rapid identification of SNPs in WGS datasets. bioRxiv http://dx.doi.org/10.1101/037267.
49. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly M, DePristo MA. 2010. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 20:1297-1303. http://dx.doi.org/10.1101/gr.107524.110.
50. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. 2013. MEGA6: Molecular evolutionary genetics analysis version 6.0. Mol Biol Evol 30:2725-2729. http://dx.doi.org/10.1093/molbev/mst197.
51. Letunic I, Bork P. 2011. Interactive Tree Of Life v2: online annotation and display of phylogenetic trees made easy. Nucleic Acids Res 39:W475-478. http://dx.doi.org/10.1093/nar/gkr201.
52. Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M, Kulikov AS, Lesin VM, Nikolenko SI, Pham S, Prjibelski AD, Pyshkin AV, Sirotkin AV, Vyahhi N, Tesler G, Alekseyev MA, Pevzner PA. 2012. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol 19:455-477. http://dx.doi.org/10.1089/cmb.2012.0021.
53. Sahl JW, Caporaso JG, Rasko DA, Keim P. 2014. The large-scale blast score ratio (LS-BSR) pipeline: a method to rapidly compare genetic content between bacterial genomes. PeerJ 2:e332. http://dx.doi.org/10.7717/peerj.332.
54. Holt KE, Wertheim H, Zadoks RN, Baker S, Whitehouse CA, Dance D, Jenney A, Connor TR, Hsu LY, Severin J, Brisse S, Cao H, Wilksch J, Gorrie C, Schultz MB, Edwards DJ, Nguyen KV, Nguyen TV, Dao TT, Mensink M, Minh VL, Nhu NT, Schultsz C, Kuntaman K, Newton PN, Moore CE, Strugnell RA, Thomson NR. 2015. Genomic analysis of diversity, population structure, virulence, and antimicrobial resistance in Klebsiella pneumoniae, an urgent threat to public health. Proc Natl Acad Sci U S A 112:E3574-3581. http://dx.doi.org/10.1073/pnas.1501049112.
55. Brisse S, Passet V, Haugaard AB, Babosan A, Kassis-Chikhani N, Struve C, Decre D. 2013. wzi Gene sequencing, a rapid method for determination of capsular type for Klebsiella strains. J Clin Microbiol 51:4073-4078. http://dx.doi.org/10.1128/JCM.01924-13.
56. Colman RE, Schupp JM, Hicks ND, Smith DE, Buchhagen JL, Valafar F, Crudu V, Romancenco E, Noroc E, Jackson L, Catanzaro DG, Rodwell TC, Catanzaro A, Keim P, Engelthaler DM. 2015. Detection of low-level mixed-population drug resistance in Mycobacterium tuberculosis using high fidelity amplicon sequencing. PLoS One 10:e0126626. http://dx.doi.org/10.1371/journal.pone.0126626.
57. Bolger AM, Lohse M, Usadel B. 2014. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30:2114-2120. http://dx.doi.org/10.1093/bioinformatics/btu170.
58. Langmead B, Salzberg SL. 2012. Fast gapped-read alignment with Bowtie 2. Nat Methods 9:357-359. http://dx.doi.org/10.1038/nmeth.1923.
59. Li H, Durbin R. 2009. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25:1754-1760. http://dx.doi.org/10.1093/bioinformatics/btp324.
60. Milne I, Stephen G, Bayer M, Cock PJ, Pritchard L, Cardle L, Shaw PD, Marshall D. 2013. Using Tablet for visual exploration of second-generation sequencing data. Brief Bioinform 14:193-202. http://dx.doi.org/10.1093/bib/bbs012.
61. Inouye M, Dashnow H, Raven LA, Schultz MB, Pope BJ, Tomita T, Zobel J, Holt KE. 2014. SRST2: rapid genomic surveillance for public health and hospital microbiology labs. Genome Med 6:90. http://dx.doi.org/10.1186/s13073-014-0090-6.
62. Li JJ, Munoz-Price LS, Spychala CN, DePascale D, Doi Y. 2016. New Delhi metallo-beta-lactamase-1-producing Klebsiella pneumoniae, Florida, USA(1). Emerg Infect Dis 22:744-746. http://dx.doi.org/10.3201/eid2204.151176.
63. Shon AS, Bajwa RP, Russo TA. 2013. Hypervirulent (hypermucoviscous) Klebsiella pneumoniae: a new and dangerous breed. Virulence 4:107-118. http://dx.doi.org/10.4161/viru.22718.
64. Davis GS, Waits K, Nordstrom L, Weaver B, Aziz M, Gauld L, Grande H, Bigler R, Horwinski J, Porter S, Stegger M, Johnson JR, Liu CM, Price LB. 2015. Intermingled Klebsiella pneumoniae populations between retail meats and human urinary tract infections. Clin Infect Dis 61:892-899. http://dx.doi.org/10.1093/cid/civ428.
65. Ocampo AM, Chen L, Cienfuegos AV, Roncancio G, Chavda KD, Kreiswirth BN, Jimenez JN. 2016. A two-year surveillance in five Colombian tertiary care hospitals reveals high frequency of non-CG258 clones of carbapenem-resistant Klebsiella pneumoniae with distinct clinical characteristics. Antimicrob Agents Chemother 60:332-342. http://dx.doi.org/10.1128/AAC.01775-15.
66. Wachino J, Shibayama K, Kurokawa H, Kimura K, Yamane K, Suzuki S, Shibata N, Ike Y, Arakawa Y. 2007. Novel plasmid-mediated 16S rRNA m1A1408 methyltransferase, NpmA, found in a clinically isolated Escherichia coli strain resistant to structurally diverse aminoglycosides. Antimicrob Agents Chemother 51:4401-4409. http://dx.doi.org/10.1128/AAC.00926-07.
67. Scott RD, II. 2009. The direct medical costs of healthcare-associated infections in U.S. hospitals and the benefits of prevention. Centers for Disease Control and Prevention, Atlanta, GA. https://www.cdc.gov/HAI/pdfs/hai/Scott-CostPaper.pdf.
68. Patel TS, Nagel JL. 2015. Clinical outcomes of Enterobacteriaceae infections stratified by carbapenem MICs. J Clin Microbiol 53:201-205. http://dx.doi.org/10.1128/JCM.03057-14.
69. Daroukh A, Delaunay C, Bigot S, Ceci JM, Siddhoun N, Bukreyeva I, Raisin J, Porcheret H, Maisonneuve L, Bouldouyre MA. 2014. Characteristics and costs of carbapenemase-producing enterobacteria carriers (2012/2013). Med Mal Infect 44:321-326. http://dx.doi.org/10.1016/j.medmal.2014.06.004.
70. van Duin D, Cober E, Richter SS, Perez F, Kalayjian RC, Salata RA, Evans S, Fowler VG, Jr, Kaye KS, Bonomo RA. 2015. Impact of therapy and strain type on outcomes in urinary tract infections caused by carbapenem-resistant Klebsiella pneumoniae. J Antimicrob Chemother 70:1203-1211. http://dx.doi.org/10.1093/jac/dku495.
71. Sahl JW, Sistrunk JR, Fraser CM, Hine E, Baby N, Begum Y, Luo Q, Sheikh A, Qadri F, Fleckenstein JM, Rasko DA. 2015. Examination of the enterotoxigenic Escherichia coli population structure during human infection. mBio 6:e00501-15. http://dx.doi.org/10.1128/mBio.00501-15.
72. Stoesser N, Sheppard AE, Moore CE, Golubchik T, Parry CM, Nget P, Saroeun M, Day NP, Giess A, Johnson JR, Peto TE, Crook DW, Walker AS, Modernizing Medical Microbiology Informatics Group. 2015. Extensive within-host diversity in fecally carried extended-spectrum-beta-lactamase-producing Escherichia coli isolates: implications for transmission analyses. J Clin Microbiol 53:2122-2131. http://dx.doi.org/10.1128/JCM.00378-15.
73. Lin MY, Lyles-Banks RD, Lolans K, Hines DW, Spear JB, Petrak R, Trick WE, Weinstein RA, Hayden MK, Centers for Disease Control and Prevention Epicenters Program. 2013. The importance of long-term acute care hospitals in the regional epidemiology of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Clin Infect Dis 57:1246-1252. http://dx.doi.org/10.1093/cid/cit500.
74. Janvier F, Delacour H, Tesse S, Larreche S, Sanmartin N, Ollat D, Rapp C, Merens A. 2014. Faecal carriage of extended-spectrum beta-lactamase-producing enterobacteria among soldiers at admission in a French military hospital after aeromedical evacuation from overseas. Eur J Clin Microbiol Infect Dis 33:1719-1723. http://dx.doi.org/10.1007/s10096-014-2141-8.
75. Allyn J, Angue M, Belmonte O, Lugagne N, Traversier N, Vandroux D, Lefort Y, Allou N. 2015. Delayed diagnosis of high drug-resistant microorganisms carriage in repatriated patients: three cases in a French intensive care unit. J Travel Med 22:215-217. http://dx.doi.org/10.1111/jtm.12194.
76. Bart Y, Paul M, Eluk O, Geffen Y, Rabino G, Hussein K. 2015. Risk factors for recurrence of carbapenem-resistant Enterobacteriaceae carriage: case-control study. Infect Control Hosp Epidemiol 36:936-941. http://dx.doi.org/10.1017/ice.2015.82.
77. Kim KR, Lee JY, Park HY, Kwak SH, Lim YJ, Hong MJ, Kim SK, Park SY, Kim HJ, Choi HS, Kim MN, Choi HR, Jeong JS, Choi SH. 2015. Clearance rate of carbapenemase-producing Enterobacteriaceae carriage among hospitalized patients. Infect Control Hosp Epidemiol 36:1361-1362. http://dx.doi.org/10.1017/ice.2015.169.
78. Torres-Gonzalez P, Cervera-Hernandez ME, Niembro-Ortega MD, Leal-Vega F, Cruz-Hervert LP, Garcia-Garcia L, Galindo-Fraga A, Martinez-Gamboa A, Bobadilla-Del Valle M, Sifuentes-Osornio J, Poncede-Leon A. 2015. Factors associated to prevalence and incidence of carbapenem-resistant Enterobacteriaceae fecal carriage: a cohort study in a Mexican tertiary care hospital. PLoS One 10:e0139883. http://dx.doi.org/10.1371/journal.pone.0139883.
79. Gagliotti C, Ciccarese V, Sarti M, Giordani S, Barozzi A, Braglia C, Gallerani C, Gargiulo R, Lenzotti G, Manzi O, Martella D, Moro ML. 2013. Active surveillance for asymptomatic carriers of carbapenemase-producing Klebsiella pneumoniae in a hospital setting. J Hosp Infect 83:330-332. http://dx.doi.org/10.1016/j.jhin.2012.11.024.
80. Ludden C, Cormican M, Vellinga A, Johnson JR, Austin B, Morris D. 2015. Colonisation with ESBL-producing and carbapenemase-producing Enterobacteriaceae, vancomycin-resistant enterococci, and meticillin-resistant Staphylococcus aureus in a long-term care facility over one year. BMC Infect Dis 15:168. http://dx.doi.org/10.1186/s12879-015-0880-5.
81. Armand-Lefèvre L, Angebault C, Barbier F, Hamelet E, Defrance G, Ruppe E, Bronchard R, Lepeule R, Lucet JC, El Mniai A, Wolff M, Montravers P, Plesiat P, Andremont A. 2013. Emergence of imipenem-resistant Gram-negative bacilli in intestinal flora of intensive care patients. Antimicrob Agents Chemother 57:1488-1495. http://dx.doi.org/10.1128/AAC.01823-12.
82. Prasad N, Labaze G, Kopacz J, Chwa S, Platis D, Pan CX, Russo D, LaBombardi VJ, Osorio G, Pollack S, Kreiswirth BN, Chen L, Urban C, Segal-Maurer S. 2016. Asymptomatic rectal colonization with carbapenem-resistant Enterobacteriaceae and Clostridium difficile among residents of a long-term care facility in New York City. Am J Infect Control 44:525-532. http://dx.doi.org/10.1016/j.ajic.2015.11.021.
83. Breurec S, Melot B, Hoen B, Passet V, Schepers K, Bastian S, Brisse S. 2016. Liver abscess caused by infection with community-acquired Klebsiella quasipneumoniae subsp. quasipneumoniae. Emerg Infect Dis 22:529-531. http://dx.doi.org/10.3201/eid2203.151466.
84. Maatallah M, Vading M, Kabir MH, Bakhrouf A, Kalin M, Naucler P, Brisse S, Giske CG. 2014. Klebsiella variicola is a frequent cause of bloodstream infection in the Stockholm area, and associated with higher mortality compared to K. pneumoniae. PLoS One 9:e113539. http://dx.doi.org/10.1371/journal.pone.0113539.
85. Sichtig H. 2016. Infectious disease next generation sequencing based diagnostic devices: microbial identification and detection of antimicrobial resistance and virulence markers, draft guidance for industry and Food and Drug Administration staff. Division of Microbiology Devices, U.S. Food and Drug Administration, Rockville, MD. http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM500441.pdf.